48,714 Shares in SiBone (NASDAQ:SIBN) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in SiBone, purchasing 48,714 shares valued at approximately $683,000, which represents about 0.11% of the company at the end of the reporting period.
• SiBone recently reported a quarterly earnings per share of ($0.15), surpassing analysts' expectations of ($0.24) and demonstrating revenue of $47.29 million.
• Insider activity included significant stock sales by executives, with SVP Michael A. Pisetsky and CFO Anshul Maheshwari selling over 8,000 shares combined, reflecting a total decrease in their positions.

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of SiBone (NASDAQ:SIBN - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The fund bought 48,714 shares of the company's stock, valued at approximately $683,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.11% of SiBone as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in SIBN. Silvercrest Asset Management Group LLC increased its stake in SiBone by 21.9% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 1,953,806 shares of the company's stock valued at $27,392,000 after purchasing an additional 350,970 shares in the last quarter. Victory Capital Management Inc. lifted its stake in SiBone by 55.0% in the first quarter. Victory Capital Management Inc. now owns 631,568 shares of the company's stock valued at $8,861,000 after acquiring an additional 224,190 shares during the last quarter. Marshall Wace LLP lifted its stake in SiBone by 332.5% in the fourth quarter. Marshall Wace LLP now owns 264,523 shares of the company's stock valued at $3,709,000 after acquiring an additional 203,361 shares during the last quarter. Nuveen Asset Management LLC raised its position in shares of SiBone by 17.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,263,988 shares of the company's stock valued at $17,721,000 after purchasing an additional 190,830 shares during the period. Finally, Lisanti Capital Growth LLC bought a new stake in SiBone in the 1st quarter valued at about $2,364,000. 98.11% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on SIBN shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $25.00 target price on shares of SiBone in a report on Tuesday, May 6th. Truist Financial boosted their price objective on SiBone from $20.00 to $22.00 and gave the stock a "buy" rating in a report on Tuesday, May 6th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $24.00 target price on shares of SiBone in a research note on Tuesday, May 6th.

Insider Buying and Selling

In related news, SVP Michael A. Pisetsky sold 3,459 shares of SiBone stock in a transaction on Friday, May 16th. The shares were sold at an average price of $19.66, for a total value of $68,003.94. Following the transaction, the senior vice president directly owned 264,636 shares of the company's stock, valued at $5,202,743.76. The trade was a 1.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Anshul Maheshwari sold 9,585 shares of SiBone stock in a transaction on Friday, May 16th. The stock was sold at an average price of $19.76, for a total transaction of $189,399.60. Following the completion of the transaction, the chief financial officer directly owned 224,507 shares in the company, valued at approximately $4,436,258.32. The trade was a 4.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 101,366 shares of company stock valued at $1,861,774 over the last quarter. Company insiders own 3.90% of the company's stock.

SiBone Price Performance

Shares of SIBN stock traded up $0.36 during trading hours on Friday, reaching $17.39. The stock had a trading volume of 571,245 shares, compared to its average volume of 309,593. The stock's fifty day simple moving average is $17.90 and its 200 day simple moving average is $16.63. The firm has a market capitalization of $741.16 million, a PE ratio of -27.17 and a beta of 0.91. The company has a current ratio of 8.53, a quick ratio of 7.26 and a debt-to-equity ratio of 0.21. SiBone has a 12 month low of $11.70 and a 12 month high of $20.05.

SiBone (NASDAQ:SIBN - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.09. SiBone had a negative net margin of 15.03% and a negative return on equity of 16.00%. The firm had revenue of $47.29 million for the quarter, compared to the consensus estimate of $45.13 million. On average, equities research analysts predict that SiBone will post -0.78 EPS for the current year.

About SiBone

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.